Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.41)
# 2,469
Out of 4,900 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $52 → $49 | $47.45 | +4.19% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $112.94 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $192.81 | +299.36% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $41.96 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $70.69 | -3.81% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $15.92 | +314.57% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $97.15 | +196.45% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $417.99 | -37.80% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $289.56 | -27.13% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $5.00 | +980.00% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $149.85 | -72.64% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $247.35 | +35.44% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $249.27 | +34.39% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $52 → $49
Current: $47.45
Upside: +4.19%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $112.94
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $192.81
Upside: +299.36%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $41.96
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $70.69
Upside: -3.81%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $15.92
Upside: +314.57%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $97.15
Upside: +196.45%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $417.99
Upside: -37.80%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $289.56
Upside: -27.13%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $5.00
Upside: +980.00%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $149.85
Upside: -72.64%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $247.35
Upside: +35.44%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $249.27
Upside: +34.39%